ClinicalTrials.Veeva

Menu
P

Parra Dermatologia | Mendoza, Argentina

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rocatinlimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 1 total trial

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PR...

Enrolling
Prurigo Nodularis
Drug: Placebo
Drug: Rocatinlimab

Trial sponsors

Amgen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems